Contact M&A Advisor






    captcha

    40 Year Old Pharmaceutical Manufacturing Business

    Description

    L#20210013

    The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.

    The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.

    They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.

    The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.

    Research

    Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.

    Studies

    Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.

    Biotechnology

    The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.

    Team

    The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.

    Market:  65% India / 35% Rest of the World / Europe

    Products:  25 OEM Products / Pharma Active Ingredients Raw Material

    Most Sold:  Antibiotics

    Standards:  ISO9001, EU Standards (No FDA)

    Growth Rate:  20%+ / Year

    Size:  100+ Employees

    Management:  Chemical Engineer Background

    Financial:  $25M Revenue / $3M EBITDA

    Customers:

    Basic Details

    Target Price:

    $40,000,000

    Gross Revenue

    $25,000,000

    EBITDA

    $3,000,000

    Business ID:

    L#20210013

    Country

    India

    City:

    Vadodara

    Detail

    Business ID:L#20210013
    Property Type:Manufacturing, Pharma
    Property Status:For Sale
    Target Price: $40,000,000
    Gross Revenue:$25,000,000
    EBITDA:$3,000,000
    Target Price / Revenue:1.6x
    Target Price / EBITDA:13.33x
    Support & Training:12 Months
    Reason for Selling:Retirement
    Contact M&A Advisor






      captcha

      Similar Businesses

      Published on December 13, 2022 at 2:46 pm. Updated on December 2, 2023 at 10:35 pm


      Premium Coal Mining

      PREVIOUS PROPERTY

      Premium Coal Mining Business

      NEXT PROPERTY

      Russian Intermodal Logistics Terminal

      Logistics Terminal

      The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.

      The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.

      They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.

      The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.

      Research

      Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.

      Studies

      Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.

      Biotechnology

      The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.

      Team

      The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.

      Market:  65% India / 35% Rest of the World / Europe

      Products:  25 OEM Products / Pharma Active Ingredients Raw Material

      Most Sold:  Antibiotics

      Standards:  ISO9001, EU Standards (No FDA)

      Growth Rate:  20%+ / Year

      Size:  100+ Employees

      Management:  Chemical Engineer Background

      Financial:  $25M Revenue / $3M EBITDA

      Customers:

      MergersCorp M&A
      International As Seen On

      • brand 1
      • brand 1
      • brand 1
      • brand 1
      • brand 1